Obesity
Diseases of the Liver and Gallbladder
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution
Overview of Lipid Metabolism
Drug Dosing: Obese Patients
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Updated: May 5, 2026

An Advanced Murine Model for Nonalcoholic Steatohepatitis in Association with Type 2 Diabetes
Published on: April 26, 2019
1Department of Medicine, Inova Fairfax Hospital, Inova Health System, VCU-Inova Campus, Beatty Center for Integrated Research, 3300 Gallows Road, Falls Church, VA 22042, USA.
No abstract available in PubMed .
08:41Novel In Vivo Micro-Computed Tomography Imaging Techniques for Assessing the Progression of Non-Alcoholic Fatty Liver Disease
Published on: March 24, 2023
07:46Isolation, Characterization, and Purification of Macrophages from Tissues Affected by Obesity-related Inflammation
Published on: April 3, 2017